All Stories

  1. Factors associated with glycaemic control and diabetes complications in patients at Bugando Medical Centre, Mwanza, Tanzania: A cross-sectional study design
  2. The comparison of the quality of selected brands of antibiotics in Tanzania sourced from different geographical regions
  3. Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania
  4. Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons
  5. Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study
  6. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community
  7. A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania
  8. Making hydroxyurea affordable for sickle cell disease in Tanzania is essential ( HASTE ): How to meet major health needs at a reasonable cost
  9. Coming together to improve access to medicines: The genesis of the East African Community’s Medicines Regulatory Harmonization initiative
  10. National medicines regulatory authorities financial sustainability in the East African Community
  11. Formulation development of chewable albendazole tablets with improved dissolution rate
  12. Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021
  13. Development and validation of simplified high-performance thin-layer chromatography densitometric methods for the determination of sulfalene, sulfadoxine, and pyrimethamine
  14. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority
  15. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market
  16. Statistics in Validation of Quantitative Chromatographic Methods
  17. Medicines Regulation in Africa: Current State and Opportunities
  18. Development and validation of a high-performance thin-layer chromatography method for the determination of artesunate and amodiaquine in tablet formulations
  19. Development of a Simple, Rapid, and Robust Isocratic Liquid Chromatographic Method for the Determination of Pyrimethamine and its Synthetic Impurities in Bulk Drugs and Pharmaceutical Formulations
  20. Development of a Qualitative near Infrared Screening Method for Quality Consistency Assessment of Virgin Sunflower Oil
  21. Post Marketing Surveillance of Anti-malarial Medicines in Tanzania
  22. Development and validation of a high-performance thin-layer chromatographic—densitometric method for the analysis of miconazole in creams
  23. Formulation development and optimization of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg FDC tablets by D-optimal mixture design
  24. The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania
  25. Development of high performance thin layer chromatography for simultaneous analysis of lamivudine and tenofovir disoproxil fumarate
  26. Smartphone-based thin layer chromatography for the discrimination of falsified medicines
  27. Development of a simple, rapid, and robust liquid chromatographic method for the simultaneous determination of sulfalene, sulfadoxine, and pyrimethamine in tablets
  28. Modeling solutions to Tanzania's physician workforce challenge
  29. Characterization of drug authenticity using thin-layer chromatography imaging with a mobile phone
  30. Routine quality control of medicines in developing countries: Analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania
  31. Pre-Formulation Development of Lamivudine 300 mg and Tenofovir Disoproxil Fumarate (TDF) 300 mg Fixed Dose Combination Tablets
  32. Assessment of Moisture Permeability and Closure Systems of High Density Polyethylene Plastic Bottles Used as Primary Packaging Containers for Moisture Sensitive Medicines
  33. Implementation of 350-2500 nm diffuse reflectance spectroscopy and High-Performance Thin-Layer Chromatography to rapidly assess manufacturing consistency and quality of cotrimoxazole tablets in Tanzania
  34. Development and validation of a generic stability-indicating MEEKC method for five fluoroquinolone antibiotics
  35. Formulation Development of Generic Omeprazole 20 mg Enteric Coated Tablets
  36. Preformulation Studies for Generic Omeprazole Magnesium Enteric Coated Tablets
  37. Development and validation of high-performance thin-layer chromatographic method for the simultaneous determination of rifampicin, isoniazid, and pyrazinamide in a fixed dosage combination tablet
  38. High-performance thin layer chromatography to assess pharmaceutical product quality
  39. Development and Validation of a Thin-Layer Chromatographic-Densitometric Method for the Analysis of Clotrimazole Vaginal Tablets
  40. The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania
  41. Screening of Substandard and Fake Drugs in Underdeveloped Countries by TLC
  42. Development and validation of a thin-layer chromatographic-densitometric method for the analysis of ciprofloxacin hydrochloride tablets
  43. Reforms: a quest for efficiency or an opportunity for vested interests’? a case study of pharmaceutical policy reforms in Tanzania
  44. Development and validation of an HPTLC-densitometric method for simultaneous analysis of lamivudine, tenofovir disoproxil fumarate, and efavirenz (LTE) in tablets
  45. The development and validation of a Thin Layer Chromatography densitometry method for the analysis of diclofenac sodium tablets
  46. Accuracy profiles assessing the validity for routine use of high-performance thin-layer chromatographic assays for drug formulations
  47. The Development and Validation of a Thin Layer Chromatography Densitometry Method for the Analysis of Diclofenac Sodium Tablets
  48. Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets
  49. HPTLC methods to assay active ingredients in pharmaceutical formulations: A review of the method development and validation steps
  50. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework
  51. Development and validation of a normal-phase HPTLC-densitometric method for the quantitative analysis of fluconazole in tablets
  52. TLC for pharmaceutical analysis in resource limited countries
  53. Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets
  54. An Interlaboratory Investigation on the Use of High-Performance Thin Layer Chromatography to Perform Assays of LamivudineZidovudine, Metronidazole, Nevirapine, and Quinine Composite Samples
  55. Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of sulfamethoxazole and trimethoprim in co-trimoxazole tablets
  56. Analysis of residual oxytetracycline in fresh milk using polymer reversed-phase column
  57. Evaluation of quality of hydrogen peroxide-based antiseptic solutions available in Dar es Salaam, Tanzania
  58. Gentamicin assay in human serum by solid-phase extraction and capillary electrophoresis
  59. Mass spectrometric study to characterize thioisoindole derivatives of aminoglycoside antibiotics
  60. Bioanalysis of tobramycin for therapeutic drug monitoring by solid-phase extraction and capillary zone electrophoresis
  61. Bioanalysis of tobramycin for therapeutic drug monitoring by solid-phase extraction and capillary zone electrophoresis
  62. Advances in capillary electrophoretically mediated microanalysis
  63. Determination of kanamycin by electrophoretically mediated microanalysis with in-capillary derivatization and UV detection
  64. Determination of kanamycin in serum by solid-phase extraction, pre-capillary derivatization and capillary electrophoresis
  65. Determination of capsaicinoids in topical cream by liquid–liquid extraction and liquid chromatography
  66. Development and validation of capillary electrophoresis method for tobramycin with precapillary derivatization and UV detection
  67. Electrophoretically mediated microanalysis of gentamicin with in-capillary derivatization and UV detection
  68. Development and validation of a simple capillary zone electrophoresis method for the analysis of kanamycin sulfate with UV detection after pre-capillary derivatization
  69. Capillary Electrophoresis analysis of gentamicin sulphate with UV detection after pre-capillary derivatization with 1,2-phthalic dicarboxaldehyde and mercaptoacetic acid
  70. Advertentie : met permissie van de ongequalificeerde kaale burgemeester Baron van Haberniks...